Daniel A. Vaena
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 16
- Prostate Cancer Treatment and Research 16
- Lung Cancer Treatments and Mutations 7
- Oncology 35
- Cancer Immunotherapy and Biomarkers 16
- Co-authors
- Sergio Bracarda (6 shared papers)Arlene O. Siefker‐Radtke (6 shared papers)Sumanta K. Pal (7 shared papers)Elizabeth R. Plimack (6 shared papers)Marc‐Oliver Grimm (4 shared papers)Janice P. Dutcher (4 shared papers)Andrea Necchi (4 shared papers)Matthew D. Galsky (3 shared papers)
- Journals
- Journal of Clinical Oncology (39 papers)Annals of Oncology (4 papers)Cancer Research (4 papers)Molecular Therapy (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
Daniel A. Vaena
63 papers receiving 2.7k citations
Daniel A. Vaena's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 1.5k
- Cancer Research 652
- Pulmonary and Respiratory Medicine 1.2k
- Surgery 1.1k
- Immunology 372
Countries citing papers authored by Daniel A. Vaena
This map shows the geographic impact of Daniel A. Vaena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Vaena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Vaena more than expected).
Fields of papers citing papers by Daniel A. Vaena
This network shows the impact of papers produced by Daniel A. Vaena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Vaena. The network helps show where Daniel A. Vaena may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Vaena, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial Hit paper breakdown → | 2017 | 1203 |
| 2 | Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206 Hit paper breakdown → | 2008 | 707 |
| 3 | 2018 | 121 | |
| 4 | 2014 | 78 | |
| 5 | 2021 | 59 | |
| 6 | 2003 | 58 | |
| 7 | 2020 | 53 | |
| 8 | 2019 | 52 | |
| 9 | 2015 | 44 | |
| 10 | 2019 | 37 | |
| 11 | 2009 | 36 | |
| 12 | 2022 | 30 | |
| 13 | 2016 | 23 | |
| 14 | 2020 | 16 | |
| 15 | 2024 | 14 | |
| 16 | 2019 | 13 | |
| 17 | 2021 | 13 | |
| 18 | 2013 | 12 | |
| 19 | 2018 | 10 | |
| 20 | 2019 | 9 |
About Daniel A. Vaena
Daniel A. Vaena is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Surgery and Molecular Biology, having authored 68 papers that have together received 2.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (19 papers), Renal cell carcinoma treatment (16 papers), Cancer Immunotherapy and Biomarkers (16 papers), Prostate Cancer Treatment and Research (16 papers), Bladder and Urothelial Cancer Treatments (15 papers), Urinary and Genital Oncology Studies (7 papers), Lung Cancer Treatments and Mutations (7 papers) and Immunotherapy and Immune Responses (6 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (652 citations), Pulmonary and Respiratory Medicine (1.2k citations), Surgery (1.1k citations) and Immunology (372 citations). Daniel A. Vaena has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Sergio Bracarda, Arlene O. Siefker‐Radtke, Sumanta K. Pal, Elizabeth R. Plimack, Marc‐Oliver Grimm, Janice P. Dutcher, Andrea Necchi, Matthew D. Galsky, Alex Azrilevich and Alexandre Lambert. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Molecular Therapy and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.